# Real-time Monitoring of Concentration and Size Variations of Circulating Plasma Free DNA to Predict Early Response to Immunotherapies in Patients With Different Types of Cancer.

> **NCT05083494** · — · UNKNOWN · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 260 (estimated)

## Conditions studied

- Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05083494
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-09
- **Primary completion:** 2023-04
- **Final completion:** 2024-04
- **Target enrollment:** 260 (ESTIMATED)
- **Last updated:** 2021-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05083494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05083494, "Real-time Monitoring of Concentration and Size Variations of Circulating Plasma Free DNA to Predict Early Response to Immunotherapies in Patients With Different Types of Cancer.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05083494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*